Inspire Medical Systems (NYSE:INSP) is 2.1% lower in thin postmarket trade after an initiation at Underperform by Oppenheimer.
The firm set a price target of $50, implying 36% downside. Shares had declined 2.6% during the regular session.
https://seekingalpha.com/news/3534970-oppenheimer-makes-bear-case-for-inspire-medical
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.